About ImmuneWatch
ImmuneWatch is a company based in Antwerp (Belgium) founded in 2021 by Tom Bosschaerts, Sander Wuyts, and Pieter Meysman. It operates as a B2B. ImmuneWatch offers products and services including ImmuneWatch DETECT and ImmuneWatch DESIGN. ImmuneWatch operates in a competitive market with competitors including AbSci, LabGenius, Ordaos, immunitoAI and Enpicom, among others.
- Headquarter Antwerp, Belgium
- Founders Tom Bosschaerts, Sander Wuyts, Pieter Meysman
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Immunewatch Bv
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ImmuneWatch
ImmuneWatch offers a comprehensive portfolio of products and services, including ImmuneWatch DETECT and ImmuneWatch DESIGN.
Extracts and annotates therapy-specific T-cell receptors from sequences.
Predicts immunogenic epitopes for vaccine development pipelines.
Funding Insights of ImmuneWatch
Detailed funding history for ImmuneWatch
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ImmuneWatch
Investment portfolio details for ImmuneWatch
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ImmuneWatch
Detailed financials for ImmuneWatch
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Immunewatch Comparisons
Peer comparison for ImmuneWatch
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ImmuneWatch
ImmuneWatch operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AbSci, LabGenius, Ordaos, immunitoAI and Enpicom, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based technology is used for recombinant protein production in therapeutics.
|
|
| Locked | Locked | Locked |
AI-driven platform for discovering and optimizing therapeutic antibodies for treatments.
|
|
| Locked | Locked | Locked |
AI accelerator provided for biomedical research and drug discovery.
|
|
| Locked | Locked | Locked |
An AI-based platform for antibody discovery and therapeutics is developed.
|
|
| Locked | Locked | Locked |
Developer of bioinformatics platform integrating data, automation, and AI for biologics
|
|
| Locked | Locked | Locked |
Therapeutic antibodies targeting complex membrane proteins are developed.
|
Detailed competitors of ImmuneWatch
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Immunewatch
Complete news archive for ImmuneWatch
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ImmuneWatch
ImmuneWatch was founded in 2021.
ImmuneWatch is headquartered in Antwerp, Belgium.
Sander Wuyts is the current CEO of ImmuneWatch. They have also founded this company.
ImmuneWatch specializes in machine learning algorithms that annotate epitope specificity of T-cell receptors from sequencing data. Based in Antwerp, Belgium, they offer ImmuneWatch DETECT for extracting therapy-specific TCRs and ImmuneWatch DESIGN for vaccine epitope prediction. The company collaborates with research institutions to analyze T-cell responses, aiding in therapeutics and diagnostics development through immunoinformatics pipelines.
ImmuneWatch's top competitors include AbSci, Ordaos and immunitoAI.
ImmuneWatch offers ImmuneWatch DETECT and ImmuneWatch DESIGN.